Illinois
[aim_melanoma_specialist] Find a Specialist The Robert H. Lurie Comprehensive Cancer Center * Northwestern University Galter Pavilion 675 N. St. Clair…
Illinois
[aim_melanoma_specialist] Find a Specialist The Robert H. Lurie Comprehensive Cancer Center * Northwestern University Galter Pavilion 675 N. St. Clair…
Iowa
[aim_melanoma_specialist] Find a Specialist The Holden Comprehensive Cancer Center * University of Iowa 200 Hawkins Dr. C32GH Iowa City, IA…
Kansas
[aim_melanoma_specialist] Find a Specialist University of Kansas Medical Center 12200 West 110th St. Overland Park, KS 66210 913-574-2707 kumc.edu Gary…
Maine
[aim_melanoma_specialist] Find a Specialist New England Cancer Specialists 100 Campus Dr., Ste 108 Scarborough, ME 04074 207-303-3300 mccm.org John Winters,…
Canada: Quebec
[aim_melanoma_specialist] Find a Specialist Hotel Dieu de Quebec 78, Place St. Laurent Quebec City, Quebec G1Y 1W7 Joel Claveau, MD…
Canada: Nova Scotia
[aim_melanoma_specialist] Find a Specialist Nova Scotia Health Authority 1276 South Park St., Bethune Building, Room 459 Halifax, N.S. B3H 2Y9…
Canada: Newfoundland
[aim_melanoma_specialist] Find a Specialist H. Bliss Murphy Cancer Centre 300 Prince Philip Drive St. John’s, NL A1B 3V6 cancercarefoundation.nl.ca 709-777-7589…
Canada: Manitoba
[aim_melanoma_specialist] Find a Specialist CancerCare Manitoba 409 Tache’ Ave. Winnipeg, Manitoba R2H 2A6 204-237-2006 cancercare.mb.ca Ralph Wong, MD……
Canada: British Columbia
[aim_melanoma_specialist] Find a Specialist British Columbia Cancer Agency 13750 96th Ave. Surrey, British Columbia V3V 1Z2 bccancer.bc.ca Christopher Lee, MD,…
Canada: Alberta
[aim_melanoma_specialist] Find a Specialist Tom Baker Centre 1331-29 Street NW Calgary, Alberta T2N 4N2 403-521-3706 albertahealthservices.ca/facilities.asp?pid=facility&rid=1007362 Tina Cheng, MSc., MD,…
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026